Rusi Zhang

436 total citations
27 papers, 248 citations indexed

About

Rusi Zhang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Rusi Zhang has authored 27 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Rusi Zhang's work include RNA modifications and cancer (7 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Rusi Zhang is often cited by papers focused on RNA modifications and cancer (7 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Rusi Zhang collaborates with scholars based in China, France and Hong Kong. Rusi Zhang's co-authors include Lanjun Zhang, Gongming Wang, Xuewen Zhang, Lanjun Zhang, Yingsheng Wen, Qifeng Chen, Wang Li, Long Zhao, Lujun Shen and Xiangyang Yu and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Oncology and Bioactive Materials.

In The Last Decade

Rusi Zhang

26 papers receiving 245 citations

Peers

Rusi Zhang

PRM

MB

CR

SURGE

ONCOL

Dezuo Dong China

Erienne M.V. de Cuba Netherlands

Chuanben Chen China

Ines Nikolovski United States

Fabian Rössler Switzerland

Katsuya Toshida Japan

He-Cheng Huang China

Jasmine J. Wang United States

Hecheng Li China

Dezuo Dong China

Rusi Zhang

77 ×0.7

PRM

119 ×1.6

MB

56 ×0.9

CR

59 ×1.0

SURGE

122 ×2.8

ONCOL

Citations per year, relative to Rusi Zhang Rusi Zhang (= 1×) peers Dezuo Dong

Countries citing papers authored by Rusi Zhang

Since Specialization

Citations

This map shows the geographic impact of Rusi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rusi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rusi Zhang more than expected).

Fields of papers citing papers by Rusi Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rusi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rusi Zhang. The network helps show where Rusi Zhang may publish in the future.

Co-authorship network of co-authors of Rusi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Rusi Zhang. A scholar is included among the top collaborators of Rusi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rusi Zhang. Rusi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

He, Xiaotian, Yiyang Ma, Yingsheng Wen, et al.. (2024). Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma. Bioactive Materials. 36. 238–255. 8 indexed citations

2.

He, Xiaotian, Rusi Zhang, Yingsheng Wen, et al.. (2023). Ten-year trends of the clinicopathological characteristics, surgical treatments and survival outcomes of operable lung cancer patients in monocenter: a retrospective cohort study. Frontiers in Medicine. 10. 1133344–1133344. 1 indexed citations

3.

Zhang, Rusi, Longjun Yang, Zirui Huang, et al.. (2023). The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study. Frontiers in Medicine. 10. 1136877–1136877. 3 indexed citations

4.

He, Xiaotian, Yiyang Ma, Gongming Wang, et al.. (2023). SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma. Thoracic Cancer. 14(23). 2275–2287. 7 indexed citations

5.

Guo, Guangran, Xiangyang Yu, Yingsheng Wen, et al.. (2022). Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma. Frontiers in Oncology. 12. 780631–780631. 5 indexed citations

6.

Guo, Guangran, Longjun Yang, Yingsheng Wen, et al.. (2022). Analysis of the tumor immune environment identifies an immune gene set–based prognostic signature in non-small cell lung cancer. Annals of Translational Medicine. 10(1). 15–15. 4 indexed citations

7.

Wen, Yingsheng, Guangran Guo, Longjun Yang, et al.. (2022). A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer. Frontiers in Molecular Biosciences. 9. 849108–849108. 2 indexed citations

8.

Zhang, Rusi, Xuewen Zhang, Han Yang, et al.. (2022). Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma. Frontiers in Genetics. 13. 968601–968601.

9.

Zhang, Rusi, Guangran Guo, Gongming Wang, et al.. (2021). Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein. Annals of Translational Medicine. 9(6). 474–474. 14 indexed citations

10.

Yu, Xiangyang, Rusi Zhang, Mengqi Zhang, et al.. (2021). Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm. Translational Lung Cancer Research. 10(2). 900–913. 10 indexed citations

11.

Wang, Weidong, Dongni Chen, Weiwei Chen, et al.. (2020). Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis. Frontiers in Oncology. 10. 855–855. 16 indexed citations

12.

Zhang, Rusi, Gongming Wang, Yongbin Lin, et al.. (2020). Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study. Translational Lung Cancer Research. 9(1). 33–44. 10 indexed citations

13.

Zhang, Rusi, Ling Cai, Gongming Wang, et al.. (2020). Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study. Frontiers in Oncology. 9. 1552–1552. 7 indexed citations

14.

Zhang, Rusi, Xuewen Zhang, Fang Wang, et al.. (2020). Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer. Translational Lung Cancer Research. 9(3). 722–730. 11 indexed citations

15.

Wang, Gongming, Lie Zheng, Lei Zhao, et al.. (2020). A new method for accurately localizing and resecting pulmonary nodules. Journal of Thoracic Disease. 12(9). 4973–4984. 7 indexed citations

16.

Cai, Ling, Weidong Wang, Fang Wang, et al.. (2019). A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation. Translational Cancer Research. 8(7). 2564–2569. 1 indexed citations

17.

Zhang, Rusi & Lanjun Zhang. (2019). Management of delayed gastric conduit emptying after esophagectomy. Journal of Thoracic Disease. 11(1). 302–307. 14 indexed citations

18.

Yu, Xiangyang, Rusi Zhang, Mengqi Zhang, et al.. (2019). Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma. Journal of Thoracic Disease. 11(9). 3980–3990. 14 indexed citations

19.

Cai, Ling, Weidong Wang, Fang Wang, et al.. (2019). A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation. Translational Cancer Research. 8(7). 2564–2569. 2 indexed citations

20.

Zhang, Rusi, et al.. (2018). Combined transarterial chemoembolization and microwave ablation versus transarterial chemoembolization in BCLC stage B hepatocellular carcinoma. Diagnostic and Interventional Radiology. 24(4). 219–224. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact